Tumour suppressors: Mystery molecule | PDF (77 KB)

p719 | doi:10.1038/nrc920

DNA repair: Small cause, large effect | PDF (135 KB)

p720 | doi:10.1038/nrc910

Drug metabolism: Not so innocent | PDF (73 KB)

p720 | doi:10.1038/nrc912

Apoptosis: Death-defining feat | PDF (89 KB)

p722 | doi:10.1038/nrc921

Therapeutics: Self destruction | PDF (89 KB)

p722 | doi:10.1038/nrc922

Mouse models: One step closer... | PDF (60 KB)

p723 | doi:10.1038/nrc916

Techniques: Welcome interference | PDF (71 KB)

p724 | doi:10.1038/nrc913

Signalling: Fuzzy logic | PDF (181 KB)

p724 | doi:10.1038/nrc919

Cell proliferation: Dual control | PDF (130 KB)

p725 | doi:10.1038/nrc911

Clinical translation of angiogenesis inhibitors

Robert Kerbel & Judah Folkman

p727 | doi:10.1038/nrc905

• Abstract
• Full Text
• PDF (793 KB)

See also: Correspondence by Millar

Transcription factors as targets for cancer therapy

James E. Darnell, Jr,

p740 | doi:10.1038/nrc906

• Abstract
• Full Text
• PDF (3,263 KB)

Ligand-targeted therapeutics in anticancer therapy

Theresa M. Allen

p750 | doi:10.1038/nrc903

• Abstract
• Full Text
• PDF (2,580 KB)

c-MYC: more than just a matter of life and death

Stella Pelengaris, Mike Khan & Gerard Evan

p764 | doi:10.1038/nrc904

• Abstract
• Full Text
• PDF (1,105 KB)

Deregulated homeobox gene expression in cancer: cause or consequence?

Cory Abate-Shen

p777 | doi:10.1038/nrc907

• Abstract
• Full Text
• PDF (3,600 KB)
• Supplementary information